Changes in the expression levels of several genes have been described in aortic aneurysm specimens, however, the spectrum of diverse molecular alterations remains to be elucidated. We attempted to identify key molecules that modulate the pathogenesis of aortic aneurysm, using a complimentary DNA microarray carrying approximately 13,000 human genes.
TAKETANI, ET AL
The prevalence of atherosclerotic thoracic aortic aneurysms (TAA) has been increasing yearly. 1, 2) Although elective surgical repair is an effective approach to prevent death from ruptured TAA, it still carries a relatively high mortality rate despite improvements in techniques. Thus, new strategies for the clinical management of TAAs are being pursued, however, little is known about the mechanisms responsible for aneurysmal formation and progression except that matrix metalloproteinases (MMPs), which are required for the breakdown of matrix proteins, have attracted interest as causative molecules of TAAs and abdominal aortic aneurysms (AAA). Since Busuttil, et al first reported that the AAA was associated with increased production of proteinases, 3) a variety of research has been performed to ascertain the increased expression of MMPs in AAAs. [4] [5] [6] Further, since the development of cDNA microarray methods, several studies have been performed to compare gene expression profiles of aneurysm specimens with those of normal aorta specimens, demonstrating many genes in aortic aneurysms were altered. [7] [8] [9] However, most of these reports compared aortic aneurysms with normal aorta obtained from non-age-matched cadavers, organ-transplant donors, or patients with aortoiliac occlusive diseases. Therefore, it remains unclear whether the differences found in gene expression were relevant to the aneurysms themselves, or were because of other factors such as age, atherosclerosis, hemodynamics, method or timing of tissue sampling, individual differences, or other systemic factors. In addition, the molecular mechanisms underlying the overexpression of MMPs are not well understood considering that the MMPs are the immediate causative molecules of aortic aneurysms.
In the present study, we used cDNA microarrays to comprehensively compare approximately 13,000 genes expressed in aortic wall tissues with and without aneurysmal changes obtained from the same patients to determine aneurysmspecific alterations and to identify factors which modulate the pathogenesis and progression of TAA. In addition to microarray analysis, the expression levels of several genes of interest were verified in the remaining specimens using real-time reverse transcription-polymerase chain reaction.
METHODS
Aortic tissues: Full-thickness aortic aneurysm specimens (TAA) were obtained from 20 patients during surgical repair of atherosclerotic aortic aneurysms in the distal aortic arch. Informed consent was obtained from all 20 participants after full explanation of the objectives and methods of the study. For comparison, an aortic wall tissue sample that did not show an aneurysmal change (NTA) was also collected from the adjacent aortic wall within 5 cm from the TAA tissue from each patient in order to eliminate any inherent biochemical differences along the Vol 46 No 2 length of the aorta. All tissue samples were harvested immediately following the aortotomy so that fresh tissue could be obtained. The specimens were washed with cold phosphate-buffered saline solution to remove blood or thrombus, and then divided into 2 parts, one of which was immediately snap-frozen in liquid nitrogen and stored at -80°C until nucleic acid extraction, while the other was submitted for pathological examination. This clinical study was approved by the University of Tokyo ethics committee and written informed consent was obtained from all patients. RNA preparation: Total RNA was isolated from a total of 40 TAA and NTA samples using an RNeasy Fibrous Tissue Mini Kit (Qiagen GmbH, Hilden, Germany). The concentration and quality of RNA was determined using an Agilent 2100 Bioanalyzer (Agilent Technologies, Wilmington, DE). The samples were preserved as total RNA and used for the microarray and quantitative RT-PCR assays. Microarray experiments: We conducted microarray assays for 5 randomly selected pairs of TAA and NTA specimens. cDNA microarrays carrying approximately 13,000 human cDNA clones (Human 1 cDNA microarray, Agilent Technologies) were purchased and fluorescence labeling and hybridization were performed according to the manufacturer's instructions. The intensity of each signal was quantified by sequential excitation of the 2 fluorophores with a scanning laser read at an appropriate wavelength for each emission (GMS 417 Array scanner, Affimetrix Santa Clara, CA, USA). Expression data were analyzed using Feature Extraction software (Agilent Technologies) as described elsewhere. 10) Differential expression values were expressed as the log ratios of the dye-normalized green and red channel signals, and then the validity of each spot on the microarray was automatically and objectively determined using the software according to the homogeneity and fluorescence intensity of each spot. If (1) the spots were saturated, (2) the fluorescence intensities were not statistically uniform, and (3) the signals were not statistically significantly intense compared with the background level using a two-tailed t-test, then the expression data for an individual gene were discarded as results of improper hybridization. Only those spots with a P value smaller than 0.05 were accepted. Real-time RT-PCR analysis : We used a real time RT-PCR (TaqMan system; Applied Biosystems, Foster City, CA) to validate the mRNA expression levels of 10 genes [MMP-1, MMP-2, MMP-3, MMP-9, a disintegrin-like and metalloprotease with thrombospondin type 1 (ADAMTS-1), tissue inhibitor of metalloproteinase-1 (TIMP-1), cathepsin D, heme oxygenase 1, caspase 4, and toll-like receptor 2] as well as glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as an internal control, in the remaining 30 samples. These subtypes of MMPs were selected for analysis because many studies have reported their involvement in the development of aortic aneurysms. The other genes were selected because they were significantly upregulated in the TAA samples in the microarray assays, and at the same time we thought it was very likely that they are involved in the pathogenesis of aneurysms considering their known functions.
Single-strand cDNA was synthesized from total RNA of 30 samples using ReverTra Ace (TOYOBO, Tokyo, Japan) and served as PCR templates. Primers and probes targeting the mRNA sequences were purchased from Applied Biosystems (TaqMan chemistry TM) and the PCR assays were performed according to the manufacturer's protocol. Each sample was tested 3 times for each gene and then standard curves were described for both the test genes and GAPDH, from which relative expression values were calculated. The expression levels of the genes of interest were then calibrated by dividing by the expression level of GAPDH. Data analysis: In the microarray analyses, the mean expression ratio of each gene was calculated as a logarithmic mean. Because of the small sample number, genes with an effect size (mean logarithmic ratio/standard deviation) of greater than 0.8 were considered significant according to Cohen's theory.
11) Quantitative RT-PCR data were not distributed normally and a Wilcoxon rank sum test was used. Differences were accepted as significant at a level of P < 0.05.
RESULTS
The clinical characteristics of the 20 participants (males; mean age, 71.2 ± 5.0 years) are shown in Table I . The mean TAA size was 59.7 ± 8.8 mm, and that of NTA was 34.5 ± 5.8 mm as measured with computed tomography. None of the lesions were associated with aortic dissection, congenital cardiovascular abnormalities, inflammatory arteriopathy such as Takayasu arteritis, or an inherited connective tissue disorder including Marfan syndrome. Histological examination: Light microscopy of the NTA samples showed a thickened intima as a type of atherosclerosis, however, significant inflammatory changes and disorganization of medial elastic fibers were nearly absent ( Figure  1A ). On the other hand, most TAA specimens had severe atherosclerosis with transmural infiltration of inflammatory cells, as well as thinned and diminished, in part, media with disrupted layers of smooth muscle cells ( Figure 1B ). There were some differences among specimens as to the extent of inflammatory cell infiltration, however, the difference was not significant. Microarray analysis: Due to the individual differences in the surgically resected specimens, there were diverse differences among the 5 comparisons. However, 220 genes showed consistent upregulation over 2 fold in TAA as compared with NTA. Listed in Table II Representative histopathological results for normal thoracic aorta (A) and thoracic aortic aneurysm (B) specimens (hematoxylin and eosin stain). A: Mildly thickened intima can ben seen, however, the elastic fibers and smooth muscle cells in the media are well preserved. Inflammatory cell infiltration is not prominent. On the other hand, B: shows more severe atherosclerosis, with a thickened intima that contains calcification. The medial layer is markedly thinned, with disorganized elastic fibers. Inflammatory cell infiltration is seen in all layers, especially in the adventitia.
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Real-time RT-PCR:
Our microarray analysis showed that the expression levels of many genes were significantly increased in TAA. Among them, we focused on MMP family genes and several other genes whose involvement in the pathogenesis of aortic aneurysms was strongly suspected for their known functions, and to verify the increased expression of these genes, real-time RT-PCR assays were performed to quantify the expression levels of MMP-2, -3, -7, and -9, TIMP-1, ADAMTS-1, cathepsin D, heme oxygenase 1, caspase 4 as well as toll-like receptor 2.
As with the data obtained from microarray assays, the expression levels of these genes, adjusted with GAPDH, were diverse from case to case, but most of the genes had also at least the tendency to be upregulated in this assay (Figure 2 ). Among these, MMP-2, MMP-9, ADAMTS-1, cathepsin D, and caspase 4 showed statistically significant overexpression in TAA.
DISCUSSION
Research into the pathogenesis of aortic aneurysms is difficult, because this disease is caused by multiple factors such as hemodynamics, metabolism, inflammation and genetic influences. 12) In addition to activation of proteolysis and inflammation, apoptosis of smooth muscle cells 13) and oxidative stress 14, 15) have been suggested by several clinicopathological studies, and these factors together with many others seem to be intricately interwoven to produce aneurysms. Another difficulty is that suitable animal models are not available for the study of aortic aneurysms. In this respect, the use of a DNA microarray technique using human samples, which can evaluate thousands of genes simultaneously, 16) is of great value and several reports have been recently published that investigated the pathophysiology of aortic aneurysms using this technique.
Tung, et al compared AAA tissues with that of normal aortas using a microarray carrying 1176 genes and found distinct patterns of gene expression reflecting chronic inflammation, extracellular matrix degradation, atherosclerosis, and smooth muscle depletion. 7) Armstrong, et al compared AAA tissue with that from aortoiliac occlusive disease and normal aortas for 265 genes, and found aneurysm-specific decreased expression of a subunit of collagen. 8) Likewise, Absi, et al reported distinct patterns of gene expression in TAA and AAA tissues by comparing 1185 genes with normal aorta specimens.
9) These and most other previous studies of human aortic aneurysms employed normal aorta samples without atherosclerosis as controls, which were obtained during autopsy or from organ donor patients without age or sex matching. However, many patients with aortic aneurysms have a medical history of hypertension and atherosclerosis, which can independently induce alterations in the cellular component, biochem-istry, and physiology of the aorta, resulting in alterations in gene expression. Therefore, it is difficult to know whether the difference in gene expression was the cause of atherosclerosis or if the aneurysm itself was based on these results. Even a comparison with aortoiliac occlusive disease tissue would not correctly show aneurysm-specific alterations because the findings may reflect the characteristics of occlusive disease. Further, we believe that the two tissue samples should be harvested in exactly the same manner to evaluate the expression levels of RNA from the participants with similar or identical ethnogenetic backgrounds.
The unique features of the present study, which compared human TAA tissues with adjacent but nonaneurysmal aorta specimens from the same patients, might have eliminated such confounding factors and enabled us to determine the genes associated with the pathogenesis of aortic aneurysms more specifically, and all the more because our TAA and NTA specimens were similar histologically. Proteinases/Proteinase inhibitors: MMPs have been reported to have an important association with the pathogenesis of arteriosclerosis and aneurysm formation. A significant and consistent upregulation of MMPs in aneurysm specimens has been reported in a majority of earlier studies, whereas increases in several MMP subtypes were not significant in our TAA/NTA comparisons. We considered 2 possible explanations for this discrepancy. First, atherosclerotic lesions (such as the NTA specimens in our study) may also produce as much MMP as aneurysmal lesions. In fact, Armstrong, et al reported that nearly equal amounts of MMP-9 were produced in aortoiliac occlusive disease and AAAs, which was significantly higher than the level in normal aortas. 8) We speculate that MMPs are necessary for vascular remodeling including aneurysm formation, however, are not sufficient to produce aneurysms independently. Second, the heterogeneity of our samples may have influenced the results. Our method was unable to detect cell-specific alterations. Although pathological examination revealed severe inflammatory changes in most TAA samples, the indiscernible differences in cell population might have given rise to the wide variety of expression levels among individuals. A microdissection technique 17) would help to resolve this issue, though comprehensive analysis of the gene expression of all cell components in a whole tissue sample is still meaningful for elucidating the comprehensive behavior of the tissue.
ADAMTS1, which was significantly upregulated in the present microarray and real-time RT-PCR assays, is an extracellular matrix degrading enzyme produced in the vascular wall and induced by prolonged exposure of endothelial cells to shear stress 18) and catalyzes the proteolysis of the extracellular matrix proteins aggrecan and vesican V1, which are often expressed in atherosclerotic human aortas. 19) Further, this gene is thought to be associated with various inflammatory Vol 46 No 2 processes and angiogenesis, making it a potential culprit for aneurysmal formation. Cathepsin D, the increased expression of which in atherosclerosis and aneurysm tissue has been well described, is a cysteine protease. 7, 20, 21) Apoptosis and inflammation: It is known that apoptosis of vascular smooth muscle cells is increased within the medial layer of aneurysmal aortic tissue. 13) In our microarray assays, apoptosis related genes such as caspase 4 and TNF family genes were upregulated.
In addition, many of the genes listed in Table II are associated with immune reactions. Although the present findings of prominent up-regulation of inflammation-related genes can be ascribed to the differences in cell population, such changes were also observed in tissues where inflammatory cell infiltration was not so severe, demonstrating that proinflammatory processes in the cell components in TAA specimens were more activated than those from the normal specimens (NTA). The up-regulated genes included small inducible cytokine A3 (CCL3), small inducible cytokine A3-like 1 (CCL3L1), lymphotoxin beta, and tumor necrosis factor (TNF, TNF alpha), which have been linked to apoptosis, cell proliferation, and cytokine production. Further, CCL3 and TNF are known to work in concert to stimulate MMP-9 synthesis in MCP-1 cells, 22, 23) while CD14 and toll-like receptor 2, also significantly upregulated, are known to generate inflammatory reactions by activating nuclear factor-kappaB, 24, 25) causing vascular lesions.
26)
Other important factors: Pleckstrin, the most significantly increased gene in TAA specimens, is known to function as a representative substrate of protein kinase C. Pleckstrin mediates activation of the mitogen-activated protein (MAP) kinase superfamily (MAPK/ERK, SAPK/JNK, p38), whose members are associated with cellular proliferation and differentiation, as well as atherosclerosis, 27) and increased transcription of MMPs. 23) Heme oxygenese-1, a cytoprotective enzyme induced by several kinds of stress, has been suggested to participate in defense mechanisms against oxidative injury and is known to be increased in myocardial infarction, atherosclerosis, postangioplasty lesions, and AAAs.
15) Hsp40-related protein, which is known to regulate the Hsp70/Hsp90 chaperon system, a defense mechanism against various types of shocks, 28) was also induced. Genes related to growth factors (insulinlike growth factor binding protein 2), cell adhesion (integrin beta 1), and vascular smooth muscle cell migration (chitinase 3-like 1) are also listed in Table II .
These genes also appeared as potent candidates responsible for aneurysms, however, all the genes in Table II should be closely evaluated by other modalities such as Northern blot or quantitative RT-PCR.
Study limitations:
This study has several limitations. First, though our method eliminated many confounding factors, the relative levels of gene expression found in the present TAA and NTA samples might have been related to differences in the severity of atherosclerosis. Second, the alterations in gene expression may not have been a cause, but rather a result of aneurysmal dilatation of the aorta. Analyses of aneurysms at an earlier stage or comparisons between aneurysms with different growth rates or with different stages may solve this problem. Third, the transcriptional alterations identified in our study will need to be confirmed at the posttranslation levels, ie, protein and protein modification levels, proceeding thereafter to functional assessment in an in vivo model. Conclusions : We have demonstrated differential expression of several hundred genes between TAA and nonaneurysmal atherosclerotic aorta specimens, including proteinases, inflammation-related genes, signaling pathway genes, apoptosisrelated genes, and oxidative stress-related genes in TAA samples. Further, many genes with unknown functions or importance were listed. Additional investigations into the functions of these genes may lead to novel therapies as a preventive strategy for TAA.
